New national COVID-19 treatment Patient Group Directions (PGDs)

The new national COVID-19 treatment Patient Group Directions (PGDs) for casirivimab and imdevimab, sotrovimab, and molnupiravir are now available for adaptation by NHS Wales Local Health Boards. You can access these via our Publications page. [updated 17 December 2021]